These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. dCas9 techniques for transcriptional repression in mammalian cells: Progress, applications and challenges. Li Y, Zhou LQ. Bioessays; 2021 Sep; 43(9):e2100086. PubMed ID: 34327721 [Abstract] [Full Text] [Related]
27. Synthetic CRISPR/dCas9-KRAB system driven by specific PSA promoter suppresses malignant biological behavior of prostate cancer cells through negative feedback inhibition of PSA expression. Yang Y, Mei H, Han X, Zhang X, Cheng J, Zhang Z, Wang H, Xu H. Cell Mol Biol Lett; 2023 Nov 28; 28(1):96. PubMed ID: 38017385 [Abstract] [Full Text] [Related]
28. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii. Markus BM, Boydston EA, Lourido S. mSphere; 2021 Oct 27; 6(5):e0047421. PubMed ID: 34643425 [Abstract] [Full Text] [Related]
31. Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model. Li R, Xia X, Wang X, Sun X, Dai Z, Huo D, Zheng H, Xiong H, He A, Wu X. PLoS Biol; 2020 Nov 27; 18(11):e3000749. PubMed ID: 33253175 [Abstract] [Full Text] [Related]
39. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis. Kabadi AM, Machlin L, Dalal N, Lee RE, McDowell I, Shah NN, Drowley L, Randell SH, Reddy TE. J Cyst Fibros; 2022 Jan 21; 21(1):164-171. PubMed ID: 34049825 [Abstract] [Full Text] [Related]